We previously reported that the CMI of an 11-gene panel (RARB, RASSF1, TWIST1, CCND2, ESR1, SCGB3A1, BRCA1, BRCA2, CDKN2A, APC, CDH1) in breast tumors increased with age. This evidence concerns the gene CDKN2A and breast neoplasm.